24 June 2026 | 12:39PM BST Equity Research Eurofins Scientific (EUFI.PA) 2Q'26 preview: Focus on ability to return to MSD organic trends in 2Q & scope for margin expansion in 1H | | | We preview Eurofins' 2Q26 results, due July 23, and reiterate our Buy rating. 1Q showed a weak start to the year with c.2.5% organic growth (affected by weather, contract exits/ disposals, reimbursement changes as well as ongoing weakness in BioPharma). While the company indicated improving trends towards the end of 1Q, we bel ...